Precipitating hydrophobic injectable liquid (PHIL; MicroVention, Aliso Viejo, CA, USA) and
Squid (Balt, Irvine, CA, USA) are 2 newer liquid embolic agents used in endovascular …

Objective To describe our early experience in treating cerebral arteriovenous malformations
(AVMs) with the new Precipitating Hydrophobic Injectable Liquid (PHIL) embolic material …

Background Precipitating hydrophobic injectable liquid is a newly introduced liquid embolic
agent for endovascular embolization with some technical advantages over other liquid …

Historically, endovascular treatment for cerebral arteriovenous malformations (AVMs) has
been reserved as an adjunct to other modalities, namely radiosurgery and microsurgery, as …

Background and purpose: Herein, we report our initial experience with the endovascular
management of cerebral arteriovenous malformations (AVMs) using the liquid embolic agent …

BACKGROUND AND PURPOSE: To report our experience in the treatment of brain
arteriovenous malformations (BAVMs) using Onyx (ev3, Irvine, Calif). Patients and …

Advancement in microcatheter design and emergence of new embolic agents offer better
results in endovascular treatment of brain arteriovenous malformations (AVMs). Precipitating …

Objectives To evaluate the safety and efficacy of a new liquid embolic agent in brain
arteriovenous malformation (bAVMs) embolisation. Methods A prospective, multicentre …

The endovascular approach to arteriovenous malformations (AVM) using different
embolizing agents is a well-established treatment option. This report assesses the results of …

The liquid embolic agents currently used for embolization of cerebral arteriovenous
malformations are Onyx and NBCA. Glubran 2, a cyanoacrylate-based synthetic glue, has …